ARECOR THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.00 GBX | 0.00% |
|
-1.84% | -56.16% |
| 09-11 | Arecor Therapeutics plc Presents Positive Data from Phase I Clinical Trial of Ultra-Concentrated, Ultra-Rapid Acting Insulins | CI |
| 07-23 | Arecor Therapeutics Completes Retail Offer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Other Biotechnology & Medical Research | 0.00% | -1.84% | -56.16% | -57.33% | - | 39.7M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- AREC Stock
- Charts Arecor Therapeutics plc
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition